Ann: OCC Signs Striate Global License And Manufacturing Agreement, page-112

“yep one of the worlds top healthcare companies is going to hand over $23m today with no guarantees to an emerging manufacturer yet to establish it's credentials in Perth.” ~@kdaly

But there are clauses and guarantees in the agreement to ensure manufacturing, supply of product and IP access including reasonable and fair clawback provisions. These appear reasonable. Did you even read the specific terms of the agreement?

But the ‘sale default’ clause appears particularly onerous on OCC and extraordinarily heavily weighted to BioHorizons. If the clause and full licence fee clawback based on a change of control of OCC is ‘standard’ as you stated, please provide a single comparable example….